Nasdaq

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

LYON, France, January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...
Seeking Alpha

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

LYON, France, January 31, 2022 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced positive clinical results from the Endo-HIFU-R1 Phase 2 study ...
Business Insider

EDAP Announces Opening of two New Ablatherm-HIFU Excellence Urology Centers in the U.S.

University of Chicago Medicine - Dr. A. Shalhav, Chair of Urology Surgery and Director of Robotic Surgery Vituro Health LLC - Dr. S. Scionti, Medical Director and Director of The Scionti Prostate ...
Business Insider

EDAP TMS SA : EDAP Announces the Installation of a Third Focal One® HIFU Device in Brazil

HIFU Prostate Cancer Treatments Successfully Performed at Albert Einstein Hospital, Sao Paulo LYON, France, September 27, 2018 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound ...
NBC News

EDAP Successfully Completes Preliminary Trial of HIFU in Liver Cancer

LYON, France, Oct. 26, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today successful completion of the first phase of the clinical protocol ...